About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

CHUGAI PHARMACEUTICAL CO., LTD.(4519) Summary

4519
TSE Prime
CHUGAI PHARMACEUTICAL CO., LTD.
6,902
JPY
+252
(+3.79%)
Dec 23, 2:13 pm JST
44.07
USD
Dec 23, 12:13 am EST
Result
PTS
outside of trading hours
6,905
Dec 23, 2:11 pm JST
Summary Chart Historical News Financial Result
PER
PBR
6.30
Yield
ー%
Margin Trading Ratio
5.77
Stock Price
Dec 23, 2024
Opening Dec 23, 9:03 am
6,821 JPY 43.58 USD
Previous Close Dec 20
6,650 JPY 42.38 USD
High Dec 23, 10:58 am
6,933 JPY 44.31 USD
Low Dec 23, 9:03 am
6,750 JPY 43.13 USD
Volume
1,113,200
Trading Value
7.63B JPY 0.05B USD
VWAP
6854.86 JPY 43.78 USD
Minimum Trading Value
690,200 JPY 4,407 USD
Market Cap
11.59T JPY 0.07T USD
Number of Trades
3,921
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
5,840
1-Year High Oct 28, 2024
21,781
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 115,500 566,300 4.90
Dec 6, 2024 120,400 584,400 4.85
Nov 29, 2024 120,100 673,400 5.61
Nov 22, 2024 137,600 793,700 5.77
Nov 15, 2024 154,800 403,400 2.61
Company Profile
CHUGAI PHARMACEUTICAL CO., LTD. is a major pharmaceutical company. As a subsidiary of Roche, it has expanded its product line, including Tamiflu. The company's main focus is on anticancer drugs and rheumatoid arthritis treatments.
Sector
Pharmaceuticals